ACXP - Acurx Pharmaceuticals GAAP EPS of -$0.26 beats by $0.07 May, 11 2022 07:15 AM Acurx Pharmaceuticals Inc. Acurx Pharmaceuticals press release (NASDAQ:ACXP): Q1 GAAP EPS of -$0.26 beats by $0.07. Cash balance of $1.08M as of March31, 2022 For further details see: Acurx Pharmaceuticals GAAP EPS of -$0.26 beats by $0.07